Vanda Pharmaceuticals Inc. (VNDA)
Market Closed
14 Aug, 20:00
$
5. 22
+0.19
+3.7773%
$
312.1M Market Cap
18.48 P/E Ratio
- Div Yield
964,700 Volume
-0.01 Eps
$ 5.03
Previous Close 
Want to track VNDA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vanda Pharmaceuticals Inc. (VNDA) Statistics
Valuation metrics
Market Cap 312.1M
Enterprise value 280.86M
Trailing P/E (ttm) -1.13
Forward P/E 30.95
PEG ratio 0.01
Price/Sales (ttm) 1.46
Price/Book (mrq) 1.43
Enterprise Value/Revenue 1.3
Enterprise Value/EBITDA -1.69
Overview
Shares outstanding 60.14M
Float 53.82M
Shares short 6.2M
% Held by insiders 0.06%
% Held by institutions 0.79%
Average volume (10 days) 964.7K
Average volume (90 days) 935.69K
Price summary
52-Week low 4.27
52-Week high 9.94
Beta 0.65
50-Day moving average 5.48
200-Day moving average 7.09
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -1.27%
Operating margin -0.86%
Operational effectiveness
Return on assets -0.67%
Return on equity -0.85%
Income Statement
Revenue (ttm) 217.78M
Revenue per share (ttm) 3.58
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 205.1M
EBITDA -151.98M
Net income to common (ttm) -239.55M
Diluted EPS (ttm) -4.56
Quarterly earnings growth (yoy) 0.03%
Balance Sheet
Total cash (mrq) 202.31M
Total cash per share (mrq) 2.82
Total debt (mrq) 13.07M
Total Debt/Equity (mrq) 0.1
Current ratio (mrq) 1.61%
Book value per share (mrq) 3.66
Cash Flow
Cash flow statement -126.51M
Levered free cash flow (LFCF) -83.15M
